Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,581 to 1,600 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond the physico-chemical barrier: Glycerol and xylitol markedly yet differentially alter gene expression profiles and modify signalling pathways in human epidermal keratinocytes. | Exp Dermatol | 2018 | 29520873 | PubTator, text mining | PubMed |
| Keratin 5/14‑mediated cell differentiation and transformation are regulated by TAp63 and Notch‑1 in oral squamous cell carcinoma‑derived cells. | Oncol Rep | 2018 | 29512781 | PubTator, text mining | PubMed |
| Anti-aging Properties of Conditioned Media of Epidermal Progenitor Cells Derived from Mesenchymal Stem Cells. | Dermatol Ther (Heidelb) | 2018 | 29500741 | PubTator, text mining | PubMed |
| Proteome analysis reveals that de novo regenerated mucosa over fibula flap-reconstructed mandibles resembles mature keratinized oral mucosa. | Oral Oncol | 2018 | 29496052 | PubTator, text mining | PubMed |
| Use of Curcumin in Psoriasis. | Open Access Maced J Med Sci | 2018 | 29484027 | PubTator, text mining | PubMed |
| Malassezia pachydermatis up-regulates AhR related CYP1A1 gene and epidermal barrier markers in human keratinocytes. | Med Mycol | 2018 | 29462476 | PubTator, text mining | PubMed |
| Laminin peptide YIGSR enhances epidermal development of skin equivalents. | J Tissue Viability | 2018 | 29428186 | PubTator, text mining | PubMed |
| Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis. | Clin Cosmet Investig Dermatol | 2018 | 29416367 | PubTator, text mining | PubMed |
| Elucidating mechanistic insights into drug action for atopic dermatitis: a systems biology approach. | BMC Dermatol | 2018 | 29415693 | PubTator, text mining | PubMed |
| Bioactive Dietary VDR Ligands Regulate Genes Encoding Biomarkers of Skin Repair That Are Associated with Risk for Psoriasis. | Nutrients | 2018 | 29401702 | PubTator, text mining | PubMed |
| Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. | Nat Med | 2018 | 29400712 | PubTator, text mining | PubMed |
| Why are preterm newborns at increased risk of infection? | Arch Dis Child Fetal Neonatal Ed | 2018 | 29382648 | PubTator, text mining | PubMed |
| Human papillomavirus E7 induces p63 expression to modulate DNA damage response. | Cell Death Dis | 2018 | 29374145 | PubTator, text mining | PubMed |
| Abnormal Sphingolipid World in Inflammation Specific for Lysosomal Storage Diseases and Skin Disorders. | Int J Mol Sci | 2018 | 29342918 | PubTator, text mining | PubMed |
| Comparison of changes in mitochondrial bioenergetics between keratinocytes in human external auditory canal skin and cholesteatomas from normoxia to hypoxia. | Sci Rep | 2018 | 29317713 | PubTator, text mining | PubMed |
| Co-Activation of Glucocorticoid Receptor and Peroxisome Proliferator-Activated Receptor-γ in Murine Skin Prevents Worsening of Atopic March. | J Invest Dermatol | 2018 | 29288652 | PubTator, text mining | PubMed |
| Biomaterials for Skin Substitutes. | Adv Healthc Mater | 2018 | 29271580 | PubTator, text mining | PubMed |
| Emerging roles for sphingolipids in cellular aging. | Curr Genet | 2018 | 29260307 | PubTator, text mining | PubMed |
| Identification of key pathways and genes in Barrett's esophagus using integrated bioinformatics methods. | Mol Med Rep | 2018 | 29257318 | PubTator, text mining | PubMed |
| Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis. | Pharmacogenomics | 2018 | 29192552 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=80